References

Review of the endocannabinoid system

2021 · External reference

Unresolved reference

2019 · External reference

Isolation, structure, and partial synthesis of an active constituent of hashish

10.1021/ja01062a046 · 1964 · External reference

Distribution of the endocannabinoid system in the central nervous system

10.1007/978-3-319-20825-1_3 · 2015 · External reference

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

10.1111/j.1432-1033.1995.tb20780.x · 1995 · External reference

Fatty acids, endocannabinoids and inflammation

10.1016/j.ejphar.2015.08.051 · 2016 · External reference

The endocannabinoid system of animals

10.3390/ani9090686 · 2019 · External reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

10.1126/science.1470919 · 1992 · External reference

Determination of the endocannabinoids anandamide and 2-arachidonoyl glycerol with gas chromatography-mass spectrometry: analytical and preanalytical challenges and pitfalls

10.1159/000489032 · 2018 · External reference

Hair levels of steroid, endocannabinoid, and the ratio biomarkers predict viral suppression among people living with HIV/AIDS in China

10.1016/j.cca.2022.08.023 · 2022 · External reference

Endocannabinoid and steroid analysis in infant and adult nails by LC-MS/MS

10.1007/s00216-022-04189-y · 2022 · External reference

Characterization of cerebral cortical endocannabinoid levels in a rat inguinal surgery model using liquid chromatography-tandem mass spectrometry (LC-MS/MS)

10.1017/ipm.2019.29 · 2022 · External reference

UPLC-MS/MS method for analysis of endocannabinoid and related lipid metabolism in mouse mucosal tissue

10.3389/fphys.2021.699712 · 2021 · External reference

Differential modulation of white adipose tissue endocannabinoid levels by n-3 fatty acids in obese mice and type 2 diabetic patients

2018 · External reference

Set up and validation of a sensitive method to quantify prostaglandins, prostaglandin-glycerol esters and prostaglandin-ethanolamides, as well as their respective precursors

10.1016/j.prostaglandins.2023.106763 · 2023 · External reference

Human milk endocannabinoid levels as a function of obesity and diurnal rhythm

10.3390/nu13072297 · 2021 · External reference

A disposable pipette extraction-UHPLC-MS/MS method based on removal of phospholipids to determine anandamide, 2-arachidonoylglycerol, cannabidiol, and Δ9-tetrahydrocannabidiol in plasma samples

10.1002/jssc.70068 · 2025 · External reference

UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches

10.1016/j.jpba.2022.115090 · 2023 · External reference

Simultaneous quantification of endocannabinoids, oleoylethanolamide and steroid hormones in human plasma and saliva

10.1016/j.jchromb.2020.122252 · 2020 · External reference

Synthesis of a deuterated standard for the quantification of 2-arachidonoylglycerol in Caenorhabditis elegans

2019 · External reference

Tricks and Tracks in the Identification and Quantification of Endocannabinoids

2013 · External reference

Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective

2011 · External reference

Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors

10.1038/bjp.2008.324 · 2008 · External reference

Cannabinoids and the expanded endocannabinoid system in neurological disorders

10.1038/s41582-019-0284-z · 2020 · External reference

Comprehensive analysis of structure-activity relationships of α-ketoheterocycles as sn-1-diacylglycerol lipase α inhibitors

10.1021/acs.jmedchem.5b01627 · 2015 · External reference

Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases

10.1016/j.bbalip.2014.12.015 · 2015 · External reference

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy

10.1111/bcp.13020 · 2016 · External reference

Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes

10.1016/j.phrs.2020.104770 · 2020 · External reference

Administration of linoleoylethanolamide reduced weight gain, dyslipidemia, and inflammation associated with high-fat-diet-induced obesity

10.3390/nu15204448 · 2023 · External reference

Clinical efficacy and biological regulations of ω-3 PUFA-derived endocannabinoids in major depressive disorder

10.1159/000501158 · 2019 · External reference

GPR110 (ADGRF1) mediates anti-inflammatory effects of N-docosahexaenoylethanolamine

10.1186/s12974-019-1621-2 · 2019 · External reference

Wholistic endocannabinoidome-microbiome-axis modulation through nutrition (WHEN) to curb obesity and related disorders

10.1186/s12944-021-01609-3 · 2022 · External reference

An integrated strategy for in-depth profiling of N-acylethanolamines in biological samples by UHPLC-HRMS

10.1016/j.aca.2024.343262 · 2024 · External reference

Construction of machine learning tools to predict threatened miscarriage in the first trimester based on AEA, progesterone and β-hCG in China: a multicentre, observational, case-control study

10.1186/s12884-022-05025-y · 2022 · External reference

Simultaneous determination of 2-arachidonoylglycerol, 1-arachidonoylglycerol and arachidonic acid in mouse brain tissue using liquid chromatography/tandem mass spectrometry

10.1002/jms.1701 · 2010 · External reference

Plasma and serum oxylipin, endocannabinoid, bile acid, steroid, fatty acid and nonsteroidal anti-inflammatory drug quantification in a 96-well plate format

10.1016/j.aca.2020.11.019 · 2021 · External reference

A simple LC-MS/MS method for the simultaneous quantification of endocannabinoids in biological samples

10.1016/j.jchromb.2020.122371 · 2020 · External reference

Quantitative lipidomic analysis of osteosarcoma cell-derived products by UHPLC-MS/MS

10.3390/biom10091302 · 2020 · External reference

A micro salting-out assisted liquid-liquid extraction combined with ultra-high performance liquid chromatography tandem mass spectrometry to determine anandamide and 2-arachidonoylglycerol in rat brain samples

10.1016/j.jchromb.2020.122351 · 2020 · External reference

Association of anandamide with altered binocular depth inversion illusion in schizophrenia

10.1080/15622975.2016.1246750 · 2017 · External reference

Endocannabinoid reactivity to acute stress: investigation of the relationship between salivary and plasma levels

10.1016/j.biopsycho.2021.108022 · 2021 · External reference

Effects of environmental heat load on endocannabinoid system components in adipose tissue of high yielding dairy cows

10.3390/ani12060795 · 2022 · External reference

Comparison of conventional and supported liquid extraction methods for the determination of sitagliptin and simvastatin in rat plasma by LC-ESI-MS/MS

10.1016/j.jpha.2014.11.003 · 2015 · External reference

In vivo solid phase microextraction for bioanalysis

10.1016/j.trac.2022.116656 · 2022 · External reference

In vivo sampling: a promising technique for detecting and profiling endogenous substances in living systems

10.1021/acs.jafc.8b06981 · 2019 · External reference

Polymeric ionic liquid open tubular capillary column for on-line in-tube SPME coupled with UHPLC-MS/MS to determine endocannabinoids in plasma samples

10.1016/j.aca.2018.08.062 · 2019 · External reference

A dual ligand sol-gel organic-silica hybrid monolithic capillary for in-tube SPME-MS/MS to determine amino acids in plasma samples

10.3390/molecules24091658 · 2019 · External reference

Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry

10.1016/j.aca.2019.09.002 · 2019 · External reference

Application of a rapid μ-SPE clean-up for multiclass quantitative analysis of sixteen new psychoactive substances in whole blood by LC–MS/MS

10.1016/j.talanta.2017.02.019 · 2017 · External reference

Determination of endocannabinoids and their conjugated congeners in the brain by means of μSPE combined with UHPLC-MS/MS

10.1016/j.talanta.2023.124392 · 2023 · External reference

Effects of rare phytocannabinoids on the endocannabinoid system of human keratinocytes

10.3390/ijms23105430 · 2022 · External reference

Determination of endocannabinoids and N-acylethanolamines in human hair with LC-MS/MS and their relation to symptoms of depression, burnout, and anxiety

10.1016/j.talanta.2020.121006 · 2020 · External reference

Study of sample preparation for determination of endocannabinoids and analogous compounds in human serum by LC–MS/MS in MRM mode

10.1016/j.talanta.2018.04.033 · 2018 · External reference

A column switching ultrahigh-performance liquid chromatography-tandem mass spectrometry method to determine anandamide and 2-arachidonoylglycerol in plasma samples

10.1007/s00216-017-0300-3 · 2017 · External reference

Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography–mass spectrometry

10.1007/s00216-021-03280-0 · 2021 · External reference

Microdialysis as an important technique in systems pharmacology-a historical and methodological review

10.1208/s12248-017-0108-2 · 2017 · External reference

Overview of brain microdialysis

2009 · External reference

Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake

10.1038/s41386-018-0055-3 · 2018 · External reference

Chemical derivatization strategy for mass spectrometry-based lipidomics

10.1002/mas.21729 · 2023 · External reference

Accurate quantification of endogenous N-acylethanolamides by chemical isotope labeling coupled with liquid chromatography-tandem mass spectrometry

10.1016/j.aca.2021.338839 · 2021 · External reference

Four-dimensional untargeted profiling of N-acylethanolamine lipids in the mouse brain using ion mobility-mass spectrometry

10.1021/acs.analchem.2c02650 · 2022 · External reference

Investigation of changes in endocannabinoids and N-acylethanolamides in biofluids, and their correlations with female infertility

10.1016/j.chroma.2017.06.029 · 2017 · External reference

Boronic derivatization of monoacylglycerol and monitoring in biofluids

10.1021/acs.analchem.9b00805 · 2019 · External reference

Boronic derivatization-based strategy for monoacylglycerol identification, isomer annotation and quantification

10.1016/j.aca.2021.339233 · 2022 · External reference

Endocannabinoids as potential biomarkers: it's all about pre-analytics

10.1016/j.jmsacl.2021.11.001 · 2021 · External reference

Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS

10.1194/jlr.d094680 · 2019 · External reference

Mechanisms underlining inflammatory pain sensitivity in mice selected for high and low stress-induced analgesia-the role of endocannabinoids and microglia

10.3390/ijms231911686 · 2022 · External reference

Optimization and validation of online column-switching assisted HPLC-spectrometric method for quantification of dansylated endocannabinoids and neurotransmitters in animal models of brain diseases

10.17352/ojabc.000016 · 2019 · External reference

HPLC fluorescence assay for measuring the activity of NAPE-PLD and the action of inhibitors affecting this enzyme

10.1016/j.jpba.2023.115354 · 2023 · External reference

Recent HPLC-UV approaches for cannabinoid analysis: from extraction to method validation and quantification compliance

10.3390/ph18060786 · 2025 · External reference

An inverse agonist of estrogen-related receptor γ regulates 2-arachidonoylglycerol synthesis by modulating diacylglycerol lipase expression in alcohol-intoxicated mice

10.1007/s00204-019-02648-7 · 2020 · External reference

Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2α) by gas chromatography–mass spectrometry-selected ion monitoring for medical samples

10.1016/s1570-0232(03)00311-8 · 2003 · External reference

Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines, Prostaglandins Leukot. Essent

10.1016/0952-3278(95)90130-2 · 1995 · External reference

Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue

10.1074/jbc.271.29.17287 · 1996 · External reference

The effects of systemic and local fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on the metabolomic profile of lungs

10.1002/bmc.5231 · 2022 · External reference

Recent applications of microextraction sample preparation techniques in biological samples analysis

10.1002/bmc.5105 · 2021 · External reference

Comparison of APPI, APCI and ESI for the LC-MS/MS analysis of bezafibrate, cyclophosphamide, enalapril, methotrexate and orlistat in municipal wastewater

10.1002/jms.1904 · 2011 · External reference

Application to several suspected poisoning cases of a validated analytical method for the determination of muscarine in human biological matrices using liquid chromatography with high-resolution mass spectrometry detection

10.1002/dta.3542 · 2024 · External reference

Modified metabolites mapping by liquid chromatography-high resolution mass spectrometry using full scan/all ion fragmentation/neutral loss acquisition

10.1016/j.chroma.2018.11.014 · 2019 · External reference

Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS

10.1194/jlr.d070433 · 2017 · External reference

Quantification of endocannabinoids in human cerebrospinal fluid using a novel micro-flow liquid chromatography-mass spectrometry method

10.1016/j.aca.2022.339888 · 2022 · External reference

Profiling the chemical differences of diterpenoid alkaloids in different processed products of aconiti lateralis radix praeparata by UHPLC-LTQ-Orbitrap mass spectrometry combined with untargeted metabolomics and mass spectrometry imaging

2025 · External reference

Stress upregulates 2-arachidonoylglycerol levels in the hypothalamus, midbrain, and hindbrain, and it is sustained by green nut oil supplementation in SAMP8 mice revealed by DESI-MSI

10.1016/j.bbrc.2022.04.004 · 2022 · External reference

Endocannabinoid 2-arachidonoylglycerol levels in the anterior cingulate cortex, caudate putamen, nucleus accumbens, and piriform cortex were upregulated by chronic restraint stress

10.3390/cells12030393 · 2023 · External reference

Modulation of neurolipid signaling and specific lipid species in the triple transgenic mouse model of Alzheimer's disease

10.3390/ijms222212256 · 2021 · External reference

Enhanced visualization of endocannabinoids spatial distribution in mouse brain via MALDI-2 mass spectrometry imaging

10.1016/j.talanta.2025.127811 · 2025 · External reference

Bioconjugation of 2-arachidonoyl glycerol (2-AG) biotinylated antibody with gold nano-flowers toward immunosensing of 2-AG in human plasma samples: a novel immuno-platform for the screening of immunomodulation and neuroprotection using biosensing

10.1039/d0ay02135k · 2021 · External reference

An innovative electrochemical immuno-platform towards ultra-sensitive monitoring of 2-arachidonoyl glycerol in samples from rats with sleep deprivation: bioanalysis of endogenous cannabinoids using biosensor technology

10.1039/d2ra00380e · 2022 · External reference

An innovative sandwich type biosensor towards sensitive and selective monitoring of 2-arachidonoylglycerol in human plasma samples using P(β-CD)-AuNPs-DDT as amplificant agent: a new immuno-platform for the recognition of endocannabinoids in real samples

10.3390/bios12100791 · 2022 · External reference

BIONOTE as an innovative biosensor for measuring endocannabinoid levels

10.3390/s21020489 · 2021 · External reference

Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case-control study

10.1186/s12902-022-01182-5 · 2022 · External reference

Endocannabinoid system and metabolism: the influences of sex

10.3390/ijms252211909 · 2024 · External reference

The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility

10.1093/humupd/dmq058 · 2011 · External reference

Dynamic changes in the endocannabinoid system during the aging process: focus on the middle-age crisis

10.3390/ijms231810254 · 2022 · External reference

Unresolved reference

2025 · External reference

Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol

10.1210/jc.2014-3455 · 2015 · External reference

Endocannabinoid signalling: has it got rhythm?

10.1111/j.1476-5381.2010.00790.x · 2010 · External reference

The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease

10.1016/j.tem.2015.07.007 · 2015 · External reference

Endocannabinoids and liver disease. I. endocannabinoids and their receptors in the liver

10.1152/ajpgi.00467.2007 · 2008 · External reference

Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease

10.1155/2014/502542 · 2014 · External reference

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration

10.1002/hep.23779 · 2010 · External reference

Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver

10.1002/hep.26598 · 2014 · External reference

F2-isoprostanes and 2-arachidonylglycerol as biomarkers of lipid peroxidation in pigs with hepatic ischemia/reperfusion injury

10.1016/j.jss.2009.01.026 · 2010 · External reference

A UPLC-MS/MS method for simultaneous determination of arachidonic acid, stearic acid, and related endocannabinoids in human plasma

10.1016/j.heliyon.2024.e28467 · 2024 · External reference

Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease

10.1002/oby.21687 · 2017 · External reference

N-3 polyunsaturated fatty acids in phospholipid or triacylglycerol form attenuate nonalcoholic fatty liver disease via mediating cannabinoid receptor 1/adiponectin/ceramide pathway

10.1016/j.jnutbio.2023.109484 · 2024 · External reference

Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease

10.1053/j.gastro.2010.06.064 · 2010 · External reference

Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis

10.1172/jci.insight.92989 · 2017 · External reference

Differential effect of interferon-alpha treatment on AEA and 2-AG levels

10.1016/j.bbi.2020.08.024 · 2020 · External reference

Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation

10.3390/ijms16047057 · 2015 · External reference

4-O’-methylhonokiol protects from alcohol/carbon tetrachloride-induced liver injury in mice

10.1007/s00109-017-1556-y · 2017 · External reference

Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis

10.1111/j.1478-3231.2009.02137.x · 2010 · External reference

The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

10.1096/fj.06-7717com · 2007 · External reference

The endocannabinoid system in cholestasis

10.1016/j.dld.2011.05.005 · 2011 · External reference

Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis

10.1136/gutjnl-2015-310212 · 2016 · External reference

Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma

2019 · External reference

Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry

10.1021/pr300683a · 2012 · External reference

Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice

10.1016/j.nbd.2005.07.008 · 2006 · External reference

Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

10.1189/jlb.0307180 · 2007 · External reference

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

10.1096/fj.06-7451com · 2007 · External reference

Hepatic cannabinoid signaling in the regulation of alcohol-associated liver disease

10.35946/arcr.v41.1.12 · 2021 · External reference

The endocannabinoid-alcohol crosstalk: recent advances on a bi-faceted target

10.1111/1440-1681.12967 · 2018 · External reference

The epidemiology, pathogenesis and histopathology of fatty liver disease

10.1111/j.1365-2559.2011.04145.x · 2012 · External reference

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome

10.1186/s13020-023-00729-5 · 2023 · External reference

The liver as an endocrine organ: linking NAFLD and insulin resistance

10.1210/er.2019-00034 · 2019 · External reference

Human liver fatty acid binding protein-1 T94A variant, nonalcohol fatty liver disease, and hepatic endocannabinoid system

10.1002/lipd.12008 · 2018 · External reference

Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism

10.1038/s41401-025-01495-w · 2025 · External reference

Anti-hepatitis B virus activities of natural products and their antiviral mechanisms

2023 · External reference

Pathobiology of liver fibrosis: a translational success story

10.1136/gutjnl-2014-306842 · 2015 · External reference

Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation

2006 · External reference

Cannabinoid receptor type I modulates alcohol-induced liver fibrosis

10.2119/molmed.2011.00149 · 2011 · External reference

Liver cancer epidemic in China: past, present and future

10.1016/j.semcancer.2010.11.002 · 2011 · External reference

The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma

10.1016/j.envres.2023.115914 · 2023 · External reference

Glutamate signaling in hepatic stellate cells drives alcoholic steatosis

10.1016/j.cmet.2019.08.001 · 2019 · External reference

Recent advances in the understanding of the role of the endocannabinoid system in liver diseases

10.1016/j.dld.2010.08.010 · 2011 · External reference

Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase

10.1096/fj.06-7705com · 2007 · External reference

Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice

10.1042/cs20130642 · 2014 · External reference

Oleoylethanolamide: a new player in peripheral control of energy metabolism. Therapeutic implications

10.1016/j.ddmec.2011.02.001 · 2010 · External reference

The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives

10.1111/liv.12263 · 2013 · External reference

Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat

10.1053/gast.2002.30305 · 2002 · External reference

Bile acid levels are increased in the liver of patients with steatohepatitis

10.1097/meg.0b013e3282f4710a · 2008 · External reference

Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide

10.1016/j.ejphar.2003.12.004 · 2004 · External reference

2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease

10.1016/j.plefa.2008.07.003 · 2008 · External reference

Autoimmune hepatitis: a review of current diagnosis and treatment

2011 · External reference

Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells

10.1124/mol.108.047035 · 2008 · External reference

The effect of oleoylethanolamide (OEA) add-on treatment on inflammatory, oxidative stress, lipid, and biochemical parameters in the acute ischemic stroke patients: randomized double-blind placebo-controlled study

10.1155/2022/5721167 · 2022 · External reference

Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats

10.1016/j.jphs.2014.12.001 · 2015 · External reference

Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells

10.18632/oncotarget.6466 · 2015 · External reference

Chronic oleoylethanolamide treatment decreases hepatic triacylglycerol level in rat liver by a PPARγ/SREBP-mediated suppression of fatty acid and triacylglycerol synthesis

10.3390/nu13020394 · 2021 · External reference

Anandamide induces cell death through lipid rafts in hepatic stellate cells

10.1111/j.1440-1746.2009.06122.x · 2010 · External reference